Page 425 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis
P. 425

Index

                         #                             adverse effects, 46, 48, 171, 187, 270, 305
                                                       adverse event, 48, 62, 86, 174, 224, 321, 324
20th century, 265, 271                                 aetiology, 11, 158, 275, 362
                                                       aetiopathogenesis, vii
                         A                             Africa, 263, 267, 341
                                                       African Americans, 182, 191, 267, 274, 338
Abraham, 166, 172                                      aggregation, 96, 102, 107, 108, 135, 312, 326
access, 321, 325                                       aggressive therapy, 305
accounting, 24, 212, 288                               aging process, 146
acetaminophen, 49                                      agranulocytosis, 391
acid, 29, 45, 102, 185, 245                            AIDS, 17, 38, 39, 58, 59, 163
acidic, 74, 101                                        airflow obstruction, 255
ACTH, 50                                               airways, 241, 288
action potential, 206                                  algorithm, 51, 76, 154, 271
actuarial methods, 304                                 allele, 68, 80, 97, 98, 100, 102, 103, 104, 105, 106,
acute promyelocytic leukemia, 246
acute renal failure, 164                                  108, 111, 115, 118, 182, 191, 192, 267, 274, 301,
acute respiratory distress syndrome, 251                  312
AD, 4, 7, 166, 330, 333, 361, 395                      allergic asthma, 243
adaptive immunity, 98                                  allergic reaction, 43
adenine, 184                                           allergic rhinitis, 349, 383
adenopathy, 190, 252, 286                              alpha interferon, 62
adhesion(s), 35, 42, 46, 69, 80, 99, 103, 110, 119,    ALT, 229
                                                       alveoli, 244
   182, 184, 185, 194, 195, 354                        alveolitis, 232, 249, 301
adipose, 140                                           amaurosis, 280, 316, 322, 339, 340, 342, 349, 357
adipose tissue, 140                                    amaurosis fugax, 316, 322, 339, 340, 342, 349, 357
adjunctive therapy, 45, 86, 284, 343                   American Heart Association, 72
adjustment, 304                                        amino, 75, 101, 102, 266
adolescents, 152                                       amino acid(s), 102, 266
adulthood, 294                                         amputation, 305
adults, 17, 23, 29, 38, 55, 70, 76, 77, 96, 145, 146,  anaphylactic reactions, 49
                                                       anaphylactoid purpura, 8, 25, 26, 54, 294, 367
   147, 148, 149, 150, 169, 199, 212, 219, 261, 262,   anastomosis, 8
   287, 294, 296, 297, 298, 325, 329, 338, 347, 355,   anatomy, 4
   373, 380, 383                                       ANCA specificity, vii, 76, 102, 131, 153, 157
advancement(s), 49, 238                                ANCA-associated vasculitides, vii, 51, 62, 76, 78,
adventitia, 4, 5, 7, 20, 27, 34, 35, 36, 38, 41, 133,     83, 86, 115, 153, 154, 159, 191, 262, 275
   313, 344, 376, 377, 378                             anemia, 162, 209, 213, 243, 304, 318, 389

Complimentary Contributor Copy
   420   421   422   423   424   425   426   427   428   429   430